{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:18:30Z","timestamp":1793726310992,"version":"4.6.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ahj.2019.11.014","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T02:04:21Z","timestamp":1575338661000},"page":"253-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Association of plasma-soluble ST2 and galectin-3 with cardiovascular events and mortality following cardiac surgery"],"prefix":"10.1016","volume":"220","author":[{"given":"Dipal M.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Thiessen-Philbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"McArthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis G.","family":"Moledina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry G.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Shlipak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay L.","family":"Koyner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kavsak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Whitlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen D.","family":"Everett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Malenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit X.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Coca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag R.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2019.11.014_bb0005","series-title":"Hyattsville (MD)","article-title":"Health, United States, 2016: With Chartbook on Long-term Trends in Health","author":"In","year":"2017"},{"issue":"2","key":"10.1016\/j.ahj.2019.11.014_bb0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCRESAHA.116.309115","article-title":"Decline in cardiovascular mortality: possible causes and implications","volume":"120","author":"Mensah","year":"2017","journal-title":"Circ Res"},{"issue":"30","key":"10.1016\/j.ahj.2019.11.014_bb0015","first-page":"649","article-title":"C, Prevention. Decline in deaths from heart disease and stroke--United States, 1900-1999","volume":"48","author":"Centers for Disease","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"23","key":"10.1016\/j.ahj.2019.11.014_bb0020","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1056\/NEJMsa053935","article-title":"Explaining the decrease in U.S. deaths from coronary disease, 1980-2000","volume":"356","author":"Ford","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ahj.2019.11.014_bb0025","first-page":"386","article-title":"Postoperative complications of patients undergoing cardiac surgery","volume":"22","author":"Ball","year":"2016","journal-title":"Curr Opin Crit Care"},{"issue":"1","key":"10.1016\/j.ahj.2019.11.014_bb0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/CIRCRESAHA.116.309955","article-title":"Novel risk markers and risk assessments for cardiovascular disease","volume":"120","author":"Thomas","year":"2017","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.ahj.2019.11.014_bb0035","first-page":"334","article-title":"Perioperative cardiac biomarkers: the utility and timing","volume":"19","author":"Beattie","year":"2013","journal-title":"Curr Opin Crit Care"},{"issue":"2","key":"10.1016\/j.ahj.2019.11.014_bb0040","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/HCO.0000000000000254","article-title":"Current and novel biomarkers in heart failure: bench to bedside","volume":"31","author":"Ghashghaei","year":"2016","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.ahj.2019.11.014_bb0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ahj.2019.11.014_bb0050","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.amjmed.2016.01.013","article-title":"Biomarkers for heart failure: an update for practitioners of internal medicine","volume":"129","author":"Wettersten","year":"2016","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.ahj.2019.11.014_bb0055","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.cardfail.2017.04.014","volume":"23","author":"Yancy","year":"2017","journal-title":"J Card Fail"},{"issue":"18","key":"10.1016\/j.ahj.2019.11.014_bb0060","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199610313351802","article-title":"Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes","volume":"335","author":"Antman","year":"1996","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ahj.2019.11.014_bb0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jtcvs.2016.02.029","article-title":"Association of cardiac biomarkers with acute kidney injury after cardiac surgery: A multicenter cohort study","volume":"152","author":"Belley-Cote","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.ahj.2019.11.014_bb0070","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/CIRCHEARTFAILURE.109.873240","article-title":"Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling","volume":"2","author":"Seki","year":"2009","journal-title":"Circ Heart Fail"},{"issue":"6","key":"10.1016\/j.ahj.2019.11.014_bb0075","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI30634","article-title":"IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system","volume":"117","author":"Sanada","year":"2007","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ahj.2019.11.014_bb0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/erm.12.128","article-title":"The Presage((R)) ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2","volume":"13","author":"Mueller","year":"2013","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.ahj.2019.11.014_bb0085","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9247574","article-title":"The many roles of galectin-3, a multifaceted molecule, in innate immune responses against pathogens","volume":"2017","author":"Diaz-Alvarez","year":"2017","journal-title":"Mediators Inflamm"},{"issue":"2","key":"10.1016\/j.ahj.2019.11.014_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020379","article-title":"Galectin-3: one molecule for an alphabet of diseases, from A to Z","volume":"19","author":"Sciacchitano","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"19","key":"10.1016\/j.ahj.2019.11.014_bb0095","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ahj.2019.11.014_bb0100","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jacc.2013.07.087","article-title":"Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3","volume":"63","author":"Bayes-Genis","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2019.11.014_bb0105","unstructured":"Meijers WC, van der Velde AR, de Boer RA. ST2 and galectin-3: ready for prime time? EJIFCC 2016;27(3):238-52."},{"issue":"16","key":"10.1016\/j.ahj.2019.11.014_bb0110","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ahj.2019.11.014_bb0115","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1681\/ASN.2010121302","article-title":"Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery","volume":"22","author":"Parikh","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ahj.2019.11.014_bb0120","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.athoracsur.2018.04.084","article-title":"The association between novel biomarkers and 1-year readmission or mortality after cardiac surgery","volume":"106","author":"Jacobs","year":"2018","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"10.1016\/j.ahj.2019.11.014_bb0125","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.athoracsur.2018.06.052","article-title":"Utility of biomarkers to improve prediction of readmission or mortality after cardiac surgery","volume":"106","author":"Brown","year":"2018","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.ahj.2019.11.014_bb0130","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1051\/ject\/201042293","article-title":"Using biomarkers to improve the preoperative prediction of death in coronary artery bypass graft patients","volume":"42","author":"Brown","year":"2010","journal-title":"J Extra Corpor Technol"},{"issue":"14","key":"10.1016\/j.ahj.2019.11.014_bb0135","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008371","article-title":"Predictive ability of novel cardiac biomarkers ST2, galectin-3, and NT-ProBNP before cardiac surgery","volume":"7","author":"Polineni","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.ahj.2019.11.014_bb0140","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1681\/ASN.2017010055","article-title":"Relationship of kidney injury biomarkers with long-term cardiovascular outcomes after cardiac surgery","volume":"28","author":"Parikh","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"21","key":"10.1016\/j.ahj.2019.11.014_bb0145","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1161\/CIRCULATIONAHA.106.635573","article-title":"Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery","volume":"114","author":"Mehta","year":"2006","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ahj.2019.11.014_bb0150","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.amjmed.2017.08.003","article-title":"Clinical applications of biomarkers in atrial fibrillation","volume":"130","author":"Chang","year":"2017","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.ahj.2019.11.014_bb0155","first-page":"599","article-title":"Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review)","volume":"41","author":"Dong","year":"2018","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.ahj.2019.11.014_bb0160","doi-asserted-by":"crossref","DOI":"10.1038\/srep40378","article-title":"Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation","volume":"7","author":"Hernandez-Romero","year":"2017","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.ahj.2019.11.014_bb0165","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/eurjhf\/hft056","article-title":"Galectin-3 and left ventricular reverse remodelling after surgical mitral valve repair","volume":"15","author":"Kortekaas","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.ahj.2019.11.014_bb0170","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1515\/cclm-2015-0074","article-title":"del Carmen Asensio-Lopez M, Sanchez-Mas J, Network G. Clinical relevance of sST2 in cardiac diseases","volume":"54","author":"Pascual-Figal","year":"2016","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"10.1016\/j.ahj.2019.11.014_bb0175","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7150\/thno.22196","article-title":"Galectin-3 activation and inhibition in heart failure and cardiovascular disease: an update","volume":"8","author":"Suthahar","year":"2018","journal-title":"Theranostics"},{"issue":"23","key":"10.1016\/j.ahj.2019.11.014_bb0180","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1161\/01.CIR.0000038705.69871.D9","article-title":"Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction","volume":"106","author":"Weinberg","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ahj.2019.11.014_bb0185","first-page":"224","article-title":"Soluble ST2 and galectin-3: what we know and don't know analytically","volume":"27","author":"Mueller","year":"2016","journal-title":"EJIFCC"},{"issue":"4","key":"10.1016\/j.ahj.2019.11.014_bb0190","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/cvr\/cvq104","article-title":"Primary sources and immunological prerequisites for sST2 secretion in humans","volume":"87","author":"Mildner","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ahj.2019.11.014_bb0195","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejphar.2017.06.031","article-title":"Interleukin-33 signaling contributes to renal fibrosis following ischemia reperfusion","volume":"812","author":"Liang","year":"2017","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"10.1016\/j.ahj.2019.11.014_bb0200","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1681\/ASN.2010091011","article-title":"IL-33 exacerbates acute kidney injury","volume":"22","author":"Akcay","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.ahj.2019.11.014_bb0205","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.hfc.2017.08.009","article-title":"Galectin-3 in Heart Failure: An Update of the Last 3 Years","volume":"14","author":"Gehlken","year":"2018","journal-title":"Heart Fail Clin"},{"issue":"2","key":"10.1016\/j.ahj.2019.11.014_bb0210","doi-asserted-by":"crossref","first-page":"H404","DOI":"10.1152\/ajpheart.00747.2008","article-title":"N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion\/growth-regulatory lectin","volume":"296","author":"Liu","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"10.1016\/j.ahj.2019.11.014_bb0215","doi-asserted-by":"crossref","first-page":"H1226","DOI":"10.1152\/ajpheart.00305.2007","article-title":"Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage","volume":"294","author":"Sharma","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.ahj.2019.11.014_bb0225","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/01902148.2013.870261","article-title":"Blockade of IL-33\/ST2 ameliorates airway inflammation in a murine model of allergic asthma","volume":"40","author":"Lee","year":"2014","journal-title":"Exp Lung Res"},{"issue":"7","key":"10.1016\/j.ahj.2019.11.014_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133774","article-title":"Vaccination against IL-33 inhibits airway hyperresponsiveness and inflammation in a house dust mite model of asthma","volume":"10","author":"Lei","year":"2015","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.ahj.2019.11.014_bb0235","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood-2014-10-606830","article-title":"The IL-33\/ST2 axis augments effector T-cell responses during acute GVHD","volume":"125","author":"Reichenbach","year":"2015","journal-title":"Blood"},{"issue":"308","key":"10.1016\/j.ahj.2019.11.014_bb0240","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aab0166","article-title":"ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease","volume":"7","author":"Zhang","year":"2015","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.ahj.2019.11.014_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083481","article-title":"Therapy of experimental NASH and fibrosis with galectin inhibitors","volume":"8","author":"Traber","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ahj.2019.11.014_bb0250","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1164\/rccm.201106-0965OC","article-title":"Regulation of transforming growth factor-beta1-driven lung fibrosis by galectin-3","volume":"185","author":"Mackinnon","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"23","key":"10.1016\/j.ahj.2019.11.014_bb0255","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1182\/blood-2012-06-438234","article-title":"Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death","volume":"120","author":"Clark","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ahj.2019.11.014_bb0260","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCHEARTFAILURE.112.971168","article-title":"Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis","volume":"6","author":"Yu","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"12","key":"10.1016\/j.ahj.2019.11.014_bb0265","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1373\/clinchem.2012.192153","article-title":"Distribution and clinical correlates of the interleukin receptor family member soluble ST2 in the Framingham Heart Study","volume":"58","author":"Coglianese","year":"2012","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.ahj.2019.11.014_bb0270","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2796.2011.02476.x","article-title":"The fibrosis marker galectin-3 and outcome in the general population","volume":"272","author":"de Boer","year":"2012","journal-title":"J Intern Med"},{"issue":"3","key":"10.1016\/j.ahj.2019.11.014_bb0275","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0002-9440(10)64595-6","article-title":"Up-regulation of galectin-3 in acute renal failure of the rat","volume":"157","author":"Nishiyama","year":"2000","journal-title":"Am J Pathol"},{"issue":"9","key":"10.1016\/j.ahj.2019.11.014_bb0280","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1681\/ASN.2012090909","article-title":"Elevated galectin-3 precedes the development of CKD","volume":"24","author":"O'Seaghdha","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.ahj.2019.11.014_bb0285","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.amjcard.2011.03.056","article-title":"Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival","volume":"108","author":"Tang","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2019.11.014_bb0290","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijcard.2016.07.241","article-title":"Determinants of temporal changes in galectin-3 level in the general population: Data of PREVEND","volume":"222","author":"van der Velde","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2019.11.014_bb0295","unstructured":"Ontario Population Projections Update 2012-2036. In. Toronto, Ontario: Ontario Ministry of Finance; 2013."},{"key":"10.1016\/j.ahj.2019.11.014_bb0300","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2147\/CLEP.S105613","article-title":"Use of the Medicare database in epidemiologic and health services research: a valuable source of real-world evidence on the older and disabled populations in the US","volume":"9","author":"Mues","year":"2017","journal-title":"Clin Epidemiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870319303321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870319303321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:04:54Z","timestamp":1757570694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870319303321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":59,"alternative-id":["S0002870319303321"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2019.11.014","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of plasma-soluble ST2 and galectin-3 with cardiovascular events and mortality following cardiac surgery","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2019.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}